Strata Financial Statements From 2010 to 2025

SRTA Stock   4.87  0.11  2.21%   
Strata Critical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Strata Critical's valuation are provided below:
Gross Profit
13.2 M
Profit Margin
(0.55)
Market Capitalization
417.3 M
Enterprise Value Revenue
1.0716
Revenue
67.2 M
We have found one hundred twenty available fundamental trend indicators for Strata Critical Medical,, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Strata Critical Medical, current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. As of December 28, 2025, Market Cap is expected to decline to about 236.1 M. In addition to that, Enterprise Value is expected to decline to about 229.4 M

Strata Critical Total Revenue

132.94 Million

Check Strata Critical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Strata Critical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.3 M, Selling General Administrative of 53 M or Selling And Marketing Expenses of 6.7 M, as well as many indicators such as Price To Sales Ratio of 1.26, Dividend Yield of 0.0 or PTB Ratio of 1.41. Strata financial statements analysis is a perfect complement when working with Strata Critical Valuation or Volatility modules.
  
Build AI portfolio with Strata Stock
Check out the analysis of Strata Critical Correlation against competitors.

Strata Critical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets276.5 M256.7 M267.7 M
Very volatile
Short and Long Term Debt Total10.1 M9.3 M4.3 M
Slightly volatile
Total Current Liabilities19.1 M22.7 M7.9 M
Slightly volatile
Total Stockholder Equity190.3 M221.9 M79.6 M
Slightly volatile
Cash19 M18.4 M8.4 M
Slightly volatile
Non Current Assets Total81.6 M95.9 M198.8 M
Slightly volatile
Cash And Short Term Investments140.9 M127.1 M231 M
Slightly volatile
Common Stock Shares Outstanding57.2 M77.5 M27.2 M
Slightly volatile
Short Term Investments152.5 M108.8 M242 M
Slightly volatile
Liabilities And Stockholders Equity276.5 M256.7 M267.7 M
Very volatile
Non Current Liabilities Total17.1 M12 MM
Slightly volatile
Other Stockholder Equity292.3 M407.1 M120.3 M
Slightly volatile
Total Liabilities62.6 M34.7 M186.7 M
Slightly volatile
Total Current Assets164.2 M160.7 M67.1 M
Slightly volatile
Short Term Debt2.5 M3.3 M1.1 M
Slightly volatile
Common Stock5.7 K8.1 K2.4 K
Slightly volatile
Property Plant And Equipment Net20.1 M39.8 M8.5 M
Slightly volatile
Current Deferred Revenue6.6 M6.7 M4.8 M
Slightly volatile
Accounts Payable20 M19 M5.4 M
Slightly volatile
Non Currrent Assets Other998.1 K1.4 M412.8 K
Slightly volatile
Net Receivables13.2 M21.6 M5.3 M
Slightly volatile
Inventory801.5 K1.3 M658.2 K
Slightly volatile
Intangible Assets23.2 M13.7 M8.4 M
Slightly volatile
Good Will36.9 M41 M19.9 M
Slightly volatile
Capital Lease Obligations14.5 M9.3 M4.7 M
Slightly volatile
Net Invested Capital204.4 M221.9 M277 M
Slightly volatile
Long Term Investments324.5 K448.5 K247.1 K
Slightly volatile
Property Plant And Equipment Gross27.8 M45.1 M11 M
Slightly volatile
Capital Stock5.6 K6.3 K6.9 K
Slightly volatile
Net Working Capital156.5 M138 M252.7 M
Slightly volatile

Strata Critical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative53 M81.7 M27.3 M
Slightly volatile
Selling And Marketing Expenses6.7 MM5.5 M
Slightly volatile
Total Revenue132.9 M248.7 M71.2 M
Slightly volatile
Gross Profit61.9 M58.9 M15.3 M
Slightly volatile
Other Operating Expenses169.9 M282.6 M92.6 M
Slightly volatile
Research Development3.1 M3.2 M1.7 M
Slightly volatile
Cost Of Revenue107.1 M189.8 M58.1 M
Slightly volatile
Total Operating Expenses62.8 M92.8 M34.5 M
Slightly volatile
Interest Expense800900981
Slightly volatile
Net Interest Income5.4 M7.2 M1.9 M
Slightly volatile
Interest Income5.4 M7.2 M1.9 M
Slightly volatile
Reconciled Depreciation5.3 MMM
Slightly volatile

Strata Critical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation20.9 M19.9 M4.7 M
Slightly volatile
Begin Period Cash Flow27.3 M29 M29.9 M
Slightly volatile
Depreciation3.7 MM1.8 M
Slightly volatile
Capital Expenditures34.6 M33 MM
Slightly volatile
End Period Cash Flow24.8 M19.6 M22.5 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.261.32444.5169
Slightly volatile
PTB Ratio1.411.48417.8109
Slightly volatile
Days Sales Outstanding24.031.688522.1401
Slightly volatile
Book Value Per Share2.082.86371.7902
Slightly volatile
Stock Based Compensation To Revenue0.05510.080.0433
Slightly volatile
Capex To Depreciation5.815.5341.3437
Slightly volatile
PB Ratio1.411.48417.8109
Slightly volatile
EV To Sales1.221.2884.2392
Slightly volatile
Inventory Turnover125126155
Slightly volatile
Days Of Inventory On Hand3.542.992.7608
Slightly volatile
Payables Turnover16.028.6120.5059
Slightly volatile
Sales General And Administrative To Revenue0.460.32860.4105
Pretty Stable
Research And Ddevelopement To Revenue0.01220.01280.0318
Slightly volatile
Capex To Revenue0.140.13270.03
Slightly volatile
Cash Per Share1.561.64053.8374
Pretty Stable
Days Payables Outstanding27.3943.8624.5131
Slightly volatile
Income Quality0.08760.09220.9003
Slightly volatile
Intangibles To Total Assets0.140.21310.0938
Slightly volatile
Net Debt To EBITDA0.350.32380.6878
Slightly volatile
Current Ratio6.77.0735.2066
Slightly volatile
Tangible Book Value Per Share1.642.15791.4586
Slightly volatile
Receivables Turnover14.5811.518417.9619
Slightly volatile
Shareholders Equity Per Share2.082.86371.7902
Slightly volatile
Debt To Equity0.03990.0420.1217
Slightly volatile
Capex Per Share0.450.42570.0827
Slightly volatile
Graham Net Net1.311.40121.0847
Slightly volatile
Revenue Per Share2.783.2092.1856
Slightly volatile
Interest Debt Per Share0.130.12030.1581
Pretty Stable
Debt To Assets0.03820.03630.077
Slightly volatile
Operating Cycle26.1231.688524.4177
Slightly volatile
Price Book Value Ratio1.411.48417.8109
Slightly volatile
Days Of Payables Outstanding27.3943.8624.5131
Slightly volatile
Ebt Per Ebit1.090.81240.9609
Pretty Stable
Effective Tax Rate0.00880.00930.0635
Slightly volatile
Company Equity Multiplier1.11.15654.8103
Very volatile
Long Term Debt To Capitalization0.03370.05950.0327
Slightly volatile
Total Debt To Capitalization0.07890.04030.1085
Slightly volatile
Debt Equity Ratio0.03990.0420.1217
Slightly volatile
Quick Ratio6.697.0735.1863
Slightly volatile
Net Income Per E B T0.770.99070.9227
Very volatile
Cash Ratio0.770.80871.662
Slightly volatile
Days Of Inventory Outstanding3.542.992.7608
Slightly volatile
Days Of Sales Outstanding24.031.688522.1401
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio14.814.09812.7157
Slightly volatile
Price To Book Ratio1.411.48417.8109
Slightly volatile
Fixed Asset Turnover10.986.24959.549
Very volatile
Debt Ratio0.03820.03630.077
Slightly volatile
Price Sales Ratio1.261.32444.5169
Slightly volatile
Asset Turnover0.50.96890.9562
Slightly volatile
Gross Profit Margin0.140.23690.1326
Slightly volatile
Price Fair Value1.411.48417.8109
Slightly volatile

Strata Critical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap236.1 M329.4 M204.3 M
Slightly volatile
Enterprise Value229.4 M320.3 M194 M
Slightly volatile

Strata Fundamental Market Drivers

About Strata Critical Financial Statements

Strata Critical stakeholders use historical fundamental indicators, such as Strata Critical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Strata Critical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Strata Critical's assets and liabilities are reflected in the revenues and expenses on Strata Critical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Strata Critical Medical,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue6.7 M6.6 M
Total Revenue248.7 M132.9 M
Cost Of Revenue189.8 M107.1 M
Stock Based Compensation To Revenue 0.08  0.06 
Sales General And Administrative To Revenue 0.33  0.46 
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.13  0.14 
Revenue Per Share 3.21  2.78 
Ebit Per Revenue(0.14)(0.14)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Strata Critical Medical, is a strong investment it is important to analyze Strata Critical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Strata Critical's future performance. For an informed investment choice regarding Strata Stock, refer to the following important reports:
Check out the analysis of Strata Critical Correlation against competitors.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Ground Transportation space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Strata Critical. If investors know Strata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Strata Critical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.24)
Revenue Per Share
1.244
Quarterly Revenue Growth
2.083
Return On Assets
(0.11)
Return On Equity
(0.24)
The market value of Strata Critical Medical, is measured differently than its book value, which is the value of Strata that is recorded on the company's balance sheet. Investors also form their own opinion of Strata Critical's value that differs from its market value or its book value, called intrinsic value, which is Strata Critical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Strata Critical's market value can be influenced by many factors that don't directly affect Strata Critical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Strata Critical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Strata Critical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Strata Critical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.